Lmcg Investments LLC Has $4.01 Million Stake in Cigna Group $CI

Lmcg Investments LLC decreased its position in shares of Cigna Group (NYSE:CI) by 3.9% during the 2nd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 12,120 shares of the health services provider’s stock after selling 494 shares during the quarter. Lmcg Investments LLC’s holdings in Cigna Group were worth $4,007,000 at the end of the most recent reporting period.

Several other hedge funds also recently modified their holdings of the company. Family Legacy Inc. boosted its holdings in shares of Cigna Group by 0.5% during the 1st quarter. Family Legacy Inc. now owns 6,497 shares of the health services provider’s stock valued at $2,138,000 after acquiring an additional 31 shares in the last quarter. Impact Investors Inc increased its stake in shares of Cigna Group by 1.6% in the first quarter. Impact Investors Inc now owns 1,975 shares of the health services provider’s stock valued at $650,000 after buying an additional 31 shares during the period. Mission Wealth Management LP increased its stake in shares of Cigna Group by 1.5% in the first quarter. Mission Wealth Management LP now owns 2,101 shares of the health services provider’s stock valued at $691,000 after buying an additional 32 shares during the period. Westend Capital Management LLC increased its stake in shares of Cigna Group by 8.1% in the first quarter. Westend Capital Management LLC now owns 427 shares of the health services provider’s stock valued at $140,000 after buying an additional 32 shares during the period. Finally, Financial Network Wealth Advisors LLC increased its stake in shares of Cigna Group by 26.8% in the first quarter. Financial Network Wealth Advisors LLC now owns 161 shares of the health services provider’s stock valued at $53,000 after buying an additional 34 shares during the period. Institutional investors and hedge funds own 86.99% of the company’s stock.

Insider Transactions at Cigna Group

In related news, insider Brian C. Evanko sold 5,368 shares of the business’s stock in a transaction dated Friday, October 3rd. The stock was sold at an average price of $300.00, for a total value of $1,610,400.00. Following the completion of the sale, the insider directly owned 51,182 shares of the company’s stock, valued at $15,354,600. The trade was a 9.49% decrease in their position. The sale was disclosed in a filing with the SEC, which is available at the SEC website. Also, insider Nicole S. Jones sold 28,526 shares of the business’s stock in a transaction dated Friday, August 15th. The shares were sold at an average price of $300.00, for a total value of $8,557,800.00. Following the completion of the sale, the insider directly owned 25,648 shares of the company’s stock, valued at $7,694,400. The trade was a 52.66% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders own 0.70% of the company’s stock.

Analyst Upgrades and Downgrades

CI has been the subject of several recent research reports. Robert W. Baird set a $372.00 price target on Cigna Group in a research note on Thursday, August 14th. TD Cowen raised Cigna Group to a “strong-buy” rating in a research note on Monday, June 23rd. Deutsche Bank Aktiengesellschaft set a $415.00 price target on Cigna Group and gave the company a “buy” rating in a research note on Tuesday, August 5th. Royal Bank Of Canada reissued an “outperform” rating and issued a $371.00 price objective on shares of Cigna Group in a research report on Thursday, June 26th. Finally, Guggenheim reissued a “buy” rating and issued a $350.00 price objective (down from $388.00) on shares of Cigna Group in a research report on Monday, August 4th. Two research analysts have rated the stock with a Strong Buy rating, fourteen have given a Buy rating and three have issued a Hold rating to the stock. Based on data from MarketBeat, the stock has an average rating of “Moderate Buy” and a consensus price target of $372.69.

Cigna Group Stock Performance

CI stock opened at $301.00 on Friday. The stock has a 50-day moving average price of $294.68 and a 200-day moving average price of $309.31. Cigna Group has a 1-year low of $256.89 and a 1-year high of $358.88. The company has a current ratio of 0.71, a quick ratio of 0.71 and a debt-to-equity ratio of 0.65. The firm has a market cap of $80.35 billion, a PE ratio of 16.43, a price-to-earnings-growth ratio of 0.90 and a beta of 0.45.

Cigna Group (NYSE:CI) last posted its quarterly earnings data on Thursday, July 31st. The health services provider reported $7.20 earnings per share for the quarter, topping the consensus estimate of $7.15 by $0.05. Cigna Group had a return on equity of 18.80% and a net margin of 1.92%.The firm had revenue of $67.13 billion during the quarter, compared to analyst estimates of $62.61 billion. During the same period last year, the company posted $6.72 EPS. The business’s quarterly revenue was up 11.0% on a year-over-year basis. Cigna Group has set its FY 2025 guidance at 29.600- EPS. As a group, equities research analysts expect that Cigna Group will post 29.77 earnings per share for the current year.

Cigna Group Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Thursday, September 18th. Investors of record on Thursday, September 4th were given a $1.51 dividend. This represents a $6.04 dividend on an annualized basis and a yield of 2.0%. The ex-dividend date of this dividend was Thursday, September 4th. Cigna Group’s payout ratio is presently 32.97%.

Cigna Group Profile

The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers.